With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...

What does the latest science say about the use of GLP-1 meds to treat obesity in people without diabetes?A review of 26 ...

Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

Retatrutide, tirzepatide, and semaglutide were most effective for weight loss in adults without diabetes ... events and treatment discontinuation. GLP-1 RAs reduce appetite, slow gastric emptying ...

GLP-1 receptor agonists include the diabetes drug Ozempic, also known as Wegovy when it’s used for weight loss. The drugs “bring people to their factory settings” by mimicking the GLP-1 hormone, which ...

Users of Ozempic and other drugs are shunning items like energy drinks and salty snacks, research shows. But there are ...

Investigational once-weekly retatrutide yielded the greatest weight loss of all GLP-1 receptor agonists, up to 22.1% after 48 weeks in adults with overweight or obesity and without diabetes ...

HealthDay News — For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious for weight loss, according to a review published ...

Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation. (HealthDay News) — For adults with overweight or obesity without ...